The course of depressive symptoms and prescribing patterns of antidepressants in schizophrenia in a one-year follow-up study

European Psychiatry

Volumn 27, Issue 4, 2012, Pages 240-244

  Lako, I M ^a,b   Taxis, K ^b   Bruggeman, R ^a,b   Knegtering, H ^a,b   Burger, H ^a   Wiersma, D ^a   Slooff, C J ^a,c  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c Centre for Intellectual Disability and Mental Health Care GGZ Drenthe   (Netherlands)

Author keywords

Antidepressant; Clinical practice; Prescribing patterns; Psychopharmacology; Psychosis; Schizophrenia

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; MOOD STABILIZER; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL HEALTH; PATIENT MONITORING; PHYSICIAN; POLYPHARMACY; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; PSYCHOSIS; RATING SCALE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCREENING TEST; SYMPTOM; TREATMENT DURATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; DEPRESSION; DRUG PRESCRIPTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; RISK FACTORS; SCHIZOPHRENIA;

EID: 84860349693     PISSN: 09249338     EISSN: 17783585     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2010.10.007     Document Type: Article

References (47)

1. Addington D., Addington J., Atkinson M. A psychometric comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale. Schizophr Res 1996, 19:205-212.
2. Addington D., Addington J., Patten S., Remington G., Moamai J., Labelle A., et al. Double-blind, placebo-controlled comparison of the efficacy of sertraline as treatment for a major depressive episode in patients with remitted schizophrenia. J Clin Psychopharmacol 2002, 22(1):20-25.
3. Practice guideline for the treatment of patients with schizophrenia 2004, American Psychiatric Association, Arlington, United States of America. 2nd ed.
4. An Der Heiden W., Konnecke R., Maurer K., Ropeter D., Hafner H. Depression in the long-term course of schizophrenia. Eur Arch Psychiatry Clin Neurosci 2005, 255:174-184.
5. An F.R., Xiang Y.T., Wang C.Y., Zhang G.P., Chiu H.F., Chan S.S., et al. Change of psychotropic drug prescription for schizophrenia in a psychiatric institution in Beijing, China between 1999 and 2008. Int J Clin Pharmacol Ther Toxicol 2010, 48:270-274.
6. Angermeyer M.C., Kuhn L., Goldstein J.M. Gender and the course of schizophrenia: differences in treated outcomes. Schizophr Bull 1990, 16:293-307.
7. Bartels S.J., Drake R.E. Depressive symptoms in schizophrenia: comprehensive differential diagnosis. Compr Psychiatry 1988, 29:467-483.
8. Baynes D., Mulholland C., Cooper S.J., Montgomery R.C., MacFlynn G., Lynch G., et al. Depressive symptoms in stable chronic schizophrenia: prevalence and relationship to psychopathology and treatment. Schizophr Res 2000, 45:47-56.
9. Birchwood M., Mason R., MacMillan F., Healy J. Depression, demoralization and control over psychotic illness: a comparison of depressed and non-depressed patients with a chronic psychosis. Psychol Med 1993, 23(2):387-395.
10. Buckley P.F., Miller B.J., Lehrer D.S., Castle D.J. Psychiatric comorbidities and schizophrenia. Schizophr Bull 2008, 35(2):383-402.
11. Carpenter W.T., Strauss J.S. The prediction of outcome in schizophrenia. IV: eleven-year follow-up of the Washington IPSS cohort. J Nerv Ment Dis 1991, 179:517-525.
12. Conley R.R., Ascher-Svanum H., Zhu B., Faries D.E., Kinon B.J. The burden of depressive symptoms in the long-term treatment of patients with schizophrenia. Schizophr Res 2007, 90:186-197.
13. DSM-IV - Diagnostic and Statistical Manual of Mental Disorders. 4th edition. Washington, DC, United States of America: American Psychiatric Association; 1994.
14. Duisterwinkel G., Bosker F.J., Scholte-Stalenhoef A.N., Vervoort M., Knegtering H. Antipsychotic augmentation strategies to ameliorate negative and cognitive symptoms in schizophrenia; implications for future research. Cent Nerv Syst Agents Med Chem 2008, 8:10-25.
15. Freudenreich O., Tranulis C., Cather C., Henderson D.C., Evins A.E., Goff D.C. Depressive symptoms in schizophrenia outpatients - Prevalence and clinical correlates. Clin Schizophr Relat Psychoses 2008, 2(2):127-135.
16. Geddes J.R., Carney S.M., Davies C., Furukawa T.A., Kupfer D.J., Frank E., et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 2003, 361:653-661.
17. Häfner H. Gender differences in schizophrenia. Psychoneuroendocrinology 2003, 28(2):17-54.
18. Harrow M., Yonan C.A., Sands J.R., Marengo J. Depression in schizophrenia: are neuroleptics, akinesia, or anhedonia involved?. Schizophr Bull 1994, 20:327-338.
19. Hirsch S.R., Jolley A.G., Barnes T.R., Liddle P.F., Curson D.A., Patel A., et al. Dysphoric and depressive symptoms in chronic schizophrenia. Schizophr Res 1989, 2:259-264.
20. Johnson D.A. Studies of depressive symptoms in schizophrenia. Br J Psychiatry 1981, 139:89-101.
21. Kaymaz N., Van Os J., Loonen A.J., Nolen W.A. Evidence that patients with single versus recurrent depressive episodes are differentially sensitive to treatment discontinuation: a meta-analysis of placebo-controlled randomized trials. J Clin Psychiatry 2008, 69:1423-1436.
22. Kirsch I., Deacon B.J., Huedo-Medina T.B., Scoboria A., Moore T.J., Johnson B.T. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med 2008, 5(2):260-268.
23. Koreen A.R., Siris S.G., Chakos M., Alvir J., Mayerhoff D., Lieberman J. Depression in first-episode schizophrenia. Am J Psychiatry 1993, 150:1643-1648.
24. Kulhara P., Avasthi A., Chadda R., Chandiramani K., Mattoo S.K., Kota S.K., et al. Negative and depressive symptoms in schizophrenia. Br J Psychiatry 1989, 154:207-211.
25. Lam R.W., Peters R., Sladen-Dew N., Altman S. A community-based clinic survey of antidepressant use in persons with schizophrenia. Can J Psychiatry 1998, 43:513-516.
26. Leff J., Tress K., Edwards B. The clinical course of depressive symptoms in schizophrenia. Schizophr Res 1988, 1:25-30.
27. Lindenmayer J.P., Kay S.R. Depression, affect and negative symptoms in schizophrenia. Br J Psychiatry 1989, 11(7):108-114.
28. Micallef J., Fakra E., Blin O. Use of antidepressant drugs in schizophrenic patients with depression. Encephale 2006, 32:263-269.
29. Mickey J., Greenland S. A study of the impact of confounder-selection criteria on effect estimation. Am J Epidemiol 1989, 128:125-137.
30. Möller H.J. Drug treatment of depressive symptoms in schizophrenia. Clin Schizophr Relat Psychoses 2008, 1(4):328-340.
31. Müller M.J. Gender-specific associations of depression with positive and negative symptoms in acute schizophrenia. Prog Neurpsychopharmacol Biol Psychiatry 2007, 31:1095-1100.
32. National Institute for Clinical Excellence (NICE). National clinical practice guideline for schizophrenia. United Kingdom; 2008.
33. Plasky P. Antidepressants usage in schizophrenia. Schizophr Bull 1991, 17(4):649-657.
34. Restifo K., Harkavy-Friedman J.M., Shrout P.E. Suicidal behavior in schizophrenia: a test of the demoralization hypothesis. J Nerv Ment Dis 2009, 197:147-153.
35. Ritsner M., Kurs R., Gibel A., Hirschmann S., Shinkarenko E., Ratner Y. Predictors of quality of life in major psychoses: a naturalistic follow-up study. J Clin Psychiatry 2003, 64:308-315.
36. Rittmannsberger H., Meise U., Schauflinger K., Horvath E., Donat H., Hinterhuber H. Polypharmacy in psychiatric treatment. Patterns of psychotropic drug use in Austrian psychiatric clinics. Eur Psychiatry 1999, 14:33-40.
37. Rocca P., Bellino S., Calvarese P., Marchiaro L., Patria L., Rasetti R., et al. Depressive and negative symptoms in schizophrenia: different effects on clinical features. Compr Psychiatry 2005, 46(4):304-310.
38. Rummel C., KisslingW, Leucht S. Antidepressants for the negative symptoms of schizophrenia. Cochrane Database Syst Rev 2006, 3:CD005581.
39. Sands J.R., Harrow M. Depression during the longitudinal course of schizophrenia. Schizophr Bull 1999, 25:157-171.
40. Schorr S.G., Slooff C.J., Bruggeman R., Taxis K. Prevalence of metabolic syndrome in patients with psychotic disorders in the Netherlands. J Clin Psychopharmacol 2009, 29(4):399-402.
41. Schorr S.G., Slooff C.J., Bruggeman R., Taxis K. The incidence of metabolic syndrome and its reversal in a cohort of schizophrenic patients followed for one year. J Psychiatric Res 2009, 43(13):1106-1111.
42. Sepehry A.A., Potvin S., Elie R., Stip E. Selective serotonin reuptake inhibitor (SSRI) add-on therapy for the negative symptoms of schizophrenia: a meta-analysis. J Clin Psychiatry 2007, 68:604-610.
43. Siris S.G., Adan F., Cohen M., Mandeli J., Aronson A., Casey E. Postpsychotic depression and negative symptoms: an investigation of syndromal overlap. Am J Psychiatry 1988, 12(145):1532-1537.
44. Siris S.G., Bench C. Depression and schizophrenia. Schizophrenia 2003, 140-167. Blackwell, Oxford, UK. 2nd ed. S. Hirsch, D. Weinberger (Eds.).
45. Trimbos-Institute. Multidisciplinary Guideline on Schizophrenia. Utrecht, The Netherlands; 2010.
46. Van Putten T., May R.P. " Akinetic depression" in schizophrenia. Arch Gen Psychiatry 1978, 35:1101-1107.
47. Whitehead C., Moss S., Cardno A., Lewis G. Antidepressants for people with both schizophrenia and depression. Cochrane Database Syst Rev 2002, 2(CD002305):1469-1493.